Epigenomics AG Validates DNA Methylation Test as Predictor of Disease Recurrence in Breast Cancer Patients
17 mai 2005 02h37 HE
|
Epigenomics AG
BERLIN, Germany, May 17, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), today revealed data confirming that its proprietary DNA methylation markers are closely correlated with...
Epigenomics AG Reports First Quarter 2005 Results
04 mai 2005 02h07 HE
|
Epigenomics AG
BERLIN, Germany, May 4, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard: ECX), today reported financial results for the first quarter ending March 31, 2005.
First Quarter...
Epigenomics AG to present at Lehman Brothers 8th Annual Global Healthcare Conference
29 mars 2005 02h15 HE
|
Epigenomics AG
BERLIN, Germany, March 29, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Oliver...